This study is testing a new approach called the Integrated Infectious Diseases and Substance Use Disorder Clinic (IC). This clinic combines care for infections and treatment for opioid or stimulant use disorder into a single appointment, which can be in person or through telemedicine. The goal is to see if this integrated care can reduce the number of times people are re-hospitalized for infections after being discharged. You might be able to join if you are 18 or older, have been hospitalized for an infection related to injecting opioids or stimulants in the past 90 days, and are currently in the hospital for a related infection. The study will measure how many times people are re-hospitalized for infections within 6 months after leaving the hospital. The current recruitment status is unclear.

Study design

This is a randomized controlled trial involving two groups, comparing the Integrated Infectious Diseases and Substance Use Disorder Clinic (IC) to usual care. About 304 participants will be enrolled across five hospitals.

What's involved

If you join, you would have at least monthly appointments for 6 months at the Integrated Infectious Diseases and Substance Use Disorder Clinic (IC), either in person or via telemedicine.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 12 months after discharge from the hospital.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.